Jan, 1 2026
Global Biosimilar Markets: Europe vs United States - How Regulatory Paths Shape Adoption and Cost Savings
Europe led the biosimilar market since 2006 with clear regulations and fast adoption. The U.S. lagged due to patents and legal barriers - until 2024, when the FDA removed key hurdles. Now both regions are accelerating growth, driving down costs for high-priced biologic drugs.
Read More